* How many can Electrome sell? * What is Electrome paying BIEL per unit as a licensing fee? * When will Electrome get their own proprietary pain device to market, and when they do, will they keep selling the ActiPatch?
I think the FDA clearances for Actipatch is what got Mayers attention and Biel’s foot in the door. The main play is the patent pending vagus nerve application which opens the door for endless opportunities in this space if it is granted FDA clearance.
Market Data 
Markets 
